Anti-Neoplastic Drugs, Corticosteroids, and Vaccines

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

flashcard set

Earn XP

Description and Tags

Vocabulary practice flashcards covering pharmacology topics including anti-neoplastic drug classes, corticosteroids, and types of immunity from the lecture transcript.

Last updated 8:36 PM on 9/24/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

21 Terms

1
New cards

Chemotherapy

The use of chemicals to kill cancer cells.

2
New cards

Cell cycle–nonspecific (CCNS) drugs

Anti-cancer drugs that act during any phase of the cell cycle, including the G0 phase (e.g., most alkylating drugs, antitumor antibiotics, and hormones).

3
New cards

Cell cycle–specific (CCS) drugs

Anti-cancer drugs that exert their influence during a specific phase of the cell cycle and are most effective against rapidly growing cancer cells (e.g., antimetabolites, vinca alkaloids).

4
New cards

Bleomycin Sulfate

A glycopeptide antibiotic/antitumor drug that affects cells during the G2 phase, indicated for leukemia, whose major adverse effect is pulmonary fibrosis.

5
New cards

Doxorubicin

An anthracycline class antineoplastic drug that interferes with DNA replication and RNA transcription in all cell cycle phases, associated with cardiotoxicity.

6
New cards

Dexrazoxane

A chemoprotectant administered before anthracyclines (like doxorubicin) to prevent cardiotoxicity.

7
New cards

Vinca Alkaloids

Plant alkaloids derived from the periwinkle plant (including Vinblastine, Vincristine, and Vinorelbine) that block cell division at the M phase leading to cell apoptosis.

8
New cards

Taxanes

Antineoplastic drugs derived from the yew tree (such as Docetaxel and Paclitaxel) that act on the M phase and whose major side effect is peripheral neuropathy.

9
New cards

Alkylating Drugs

Cell cycle–nonspecific (CCNS) anti-cancer drugs that damage cell DNA by cross-linkage of DNA strands, abnormal base pairing, or DNA strand breaks.

10
New cards

Cyclophosphamide

A nitrogen mustard alkylating agent used for various lymphomas, leukemias, and lupus nephritis, whose major adverse effect is hemorrhagic cystitis.

11
New cards

Sodium 2-mercaptoethanesulfonate

An agent whose administration is anticipated in nursing management to help protect against cyclophosphamide-induced hemorrhagic cystitis.

12
New cards

Nitrosoureas

A class of alkylating drugs (including Carmustine, Lomustine, and Streptozocin) that cross the blood-brain barrier to treat brain cancer, causing neurotoxicity as a major side effect.

13
New cards

Busulfan

An alkylsulfonate class antineoplastic agent whose major side effect is pulmonary fibrosis.

14
New cards

Antimetabolites

Cell cycle–specific (CCS) anti-cancer drugs that exert their effects during the S phase (DNA synthesis and metabolism) of the cell cycle.

15
New cards

Methotrexate

A folate analogue antimetabolite that inhibits AICAR transformylase, used to treat rheumatoid arthritis, psoriasis, ectopic pregnancies, and various cancers.

16
New cards

Leucovorin

A agent given 1212 to 24 hours24\text{ hours} after methotrexate administration to reduce AICAR concentrations and diminish adverse toxic effects.

17
New cards

Corticosteroids

A class of C21C_{21} steroid hormones produced in the adrenal cortex that lower inflammation and suppress immunity by entering cells and changing gene transcription.

18
New cards

Natural Active Immunity

Immunity acquired when a person gets a disease or infection and their own body makes antibodies.

19
New cards

Artificial Active Immunity

Immunity acquired when a person receives a vaccine, prompting their body to make antibodies.

20
New cards

Natural Passive Immunity

Immunity acquired through maternal antibodies passed from another person (e.g., via breast milk or placenta).

21
New cards

Artificial Passive Immunity

Immunity acquired by receiving pre-formed antibodies or immune globulin produced by another person.